Fulcrum Therapeutics, Inc. entered into a definitive Agreement and Plan of Merger with Slate Medicines, Inc., on August 16, 2026, to combine in an all-stock transaction intended as a tax-free reorganization. Pre-merger Fulcrum stockholders are expected to own approximately 5.0% of the combined company, while pre-merger Slate stockholders and concurrent investors will own 95.0%. The deal includes a $245 million concurrent private placement financing led by Frazier Life Sciences. Fulcrum expects to declare an aggregate cash dividend of $270 million to its existing shareholders prior to closing. The combined entity will operate as Slate Medicines, Inc., with Slate’s board serving as the new board and Gregory Oakes as CEO. Fulcrum Therapeutics is a clinical-stage biopharmaceutical company focused on developing small molecules for rare hematological disorders.

Greg Tourangeau departed as Vice President of Finance and principal accounting officer on August 7, 2026, following a mutual agreement previously disclosed in June. Alan Musso, the company's chief financial officer and principal financial officer, was appointed as principal accounting officer effective August 7, 2026, with no additional compensation. Fulcrum Therapeutics operates in the biotechnology industry, focusing on developing treatments for rare genetic diseases.

Following the discontinuation of pociredir for sickle cell disease, Fulcrum Therapeutics implemented a restructuring plan to reduce expenses. On June 5 and June 11, 2026, the company approved cash retention payments for its nine remaining full-time employees, including $370,040 for CEO Alex C. Sapir, $195,480 for CLO Curtis Oltmans, and $195,200 for CFO Alan Musso, payable upon a Change in Control or termination without Cause. Additionally, the company announced that Greg Tourangeau, VP of Finance and principal accounting officer, will depart on a mutually agreed date, noting no disagreements over financial reporting. Fulcrum Therapeutics is a biotechnology company that develops therapies for rare diseases.